Many people have a genetic predisposition to obesity, but gene defects that guarantee obesity are rare. Here's what you need ...

A new report led by researchers at Pennington Biomedical Research Center underscores the growing potential of precision ...

Adult obesity is rising in the United States, with a greater impact on racial and ethnic minorities, a U.S. Centers for Disease Control (CDC) report showed, at a time when the health condition is seen ...

Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

Novo Nordisk is set to buy US liver disease biotech Akero Therapeutics for up to $5.2bn, as the Danish drugmaker seeks to ...

The study found that under permanent standard time, obesity would be reduced by 0.78% which equates to a reduction in 2.6 ...

Researchers conducted a cross-sectional analysis utilizing data from the 2019 National Survey of Children’s Health to assess the link between household food insecurity and obesity in US adolescents. A ...

Obesity has been linked to diseases like diabetes, heart disease, and hypertension for a long time. Excess weight is now ...

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ®) achieved significant weight loss, with one in three study participants losing 20% or more body weight 1 ** Oral semaglutide 25 mg ...

Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, another effort to counter Eli Lilly & Co. in the booming obesity market.

Novo Nordisk is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – ...

Eli Lilly & Co.’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said.